SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (18860)2/17/1999 7:00:00 PM
From: DaiS  Read Replies (1) of 23519
 
Mk,

Are you say that Zeneca reps might start selling muse before the merger?

All what is happening is a total puzzle to me...Vivus do have good news of various kinds to put out....

I do feel that this ED thing is a unique situation and with muse sales fraction of peak levels in US and with publicity about all these other treatments in press etc...few can believe it possible that Vivus has a future...we been through it all before.

The only reasonable explanation for Vivus behaviour is that Vivus consider the share price irrelevant at present or they want it to go down for reasons already given here....perhaps they calculate that hype now will be totally ineffecitve and waste shot..

In UK now we have incrediable media campaign against genetically modified food...like two weeks ago against the England soccer manager becasue he said he believed in reincarnation and kharma and he was forced to resign. Probably government will do some ban just on the basis of media hype..

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext